Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seo

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 23, 2018
Serum S100 Proteins as a Marker of Disease Activity in Large Vessel VasculitisJason Michael Springer, Paul Monach, David Cuthbertson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2021
ReplyLauren A Henderson, Kevin G Friedman, Mary Beth F Son, et al.
Clinical and Experimental Rheumatology|March 11, 2017
IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Esha Oommen, Amber Hummel, Lisa Allmannsberger, et al.
The Journal of Rheumatology|September 3, 2019
Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of VasculitisAlicia Rodriguez-Pla, Roscoe L Warner, David Cuthbertson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated VasculitisRuth J Pepper, Juliana B Draibe, Ben Caplin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2018
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
Clinical Immunology (Orlando, Fla.)|March 6, 2023
Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitisDespina Michailidou, Runa Kuley, Ting Wang, et al.
American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.
Arthritis Research & Therapy|June 29, 2022
Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitisDespina Michailidou, Bhargavi Duvvuri, Runa Kuley, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remissionGabriele Gamerith, Finn Mildner, Peter A Merkel, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 23, 2018
Serum S100 Proteins as a Marker of Disease Activity in Large Vessel VasculitisJason Michael Springer, Paul Monach, David Cuthbertson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 15, 2021
ReplyLauren A Henderson, Kevin G Friedman, Mary Beth F Son, et al.
Clinical and Experimental Rheumatology|March 11, 2017
IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Esha Oommen, Amber Hummel, Lisa Allmannsberger, et al.
The Journal of Rheumatology|September 3, 2019
Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of VasculitisAlicia Rodriguez-Pla, Roscoe L Warner, David Cuthbertson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2016
Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated VasculitisRuth J Pepper, Juliana B Draibe, Ben Caplin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2018
Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated VasculitisAlvise Berti, Roscoe Warner, Kent Johnson, et al.
Clinical Immunology (Orlando, Fla.)|March 6, 2023
Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitisDespina Michailidou, Runa Kuley, Ting Wang, et al.
American Journal of Nephrology|September 8, 2017
Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated GlomerulonephritisDuvuru Geetha, Sanjeev Sethi, An S De Vriese, et al.
Arthritis Research & Therapy|June 29, 2022
Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitisDespina Michailidou, Bhargavi Duvvuri, Runa Kuley, et al.
Annals of the Rheumatic Diseases|August 16, 2022
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remissionGabriele Gamerith, Finn Mildner, Peter A Merkel, et al.
Pageof 17